Suppr超能文献

TIPE2,一种维持免疫稳态的先天性和适应性免疫的负调节因子。

TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis.

作者信息

Sun Honghong, Gong Shunyou, Carmody Ruaidhri J, Hilliard Anja, Li Li, Sun Jing, Kong Li, Xu Lingyun, Hilliard Brendan, Hu Shimin, Shen Hao, Yang Xiaolu, Chen Youhai H

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Cell. 2008 May 2;133(3):415-26. doi: 10.1016/j.cell.2008.03.026.

Abstract

Immune homeostasis is essential for the normal functioning of the immune system, and its breakdown leads to fatal inflammatory diseases. We report here the identification of a member of the tumor necrosis factor-alpha-induced protein-8 (TNFAIP8) family, designated TIPE2, that is required for maintaining immune homeostasis. TIPE2 is preferentially expressed in lymphoid tissues, and its deletion in mice leads to multiorgan inflammation, splenomegaly, and premature death. TIPE2-deficient animals are hypersensitive to septic shock, and TIPE2-deficient cells are hyper-responsive to Toll-like receptor (TLR) and T cell receptor (TCR) activation. Importantly, TIPE2 binds to caspase-8 and inhibits activating protein-1 and nuclear factor-kappaB activation while promoting Fas-induced apoptosis. Inhibiting caspase-8 significantly blocks the hyper-responsiveness of TIPE2-deficient cells. These results establish that TIPE2 is an essential negative regulator of TLR and TCR function, and its selective expression in the immune system prevents hyperresponsiveness and maintains immune homeostasis.

摘要

免疫稳态对于免疫系统的正常运作至关重要,其失衡会导致致命的炎症性疾病。我们在此报告肿瘤坏死因子-α诱导蛋白8(TNFAIP8)家族的一个成员的鉴定,该成员命名为TIPE2,它是维持免疫稳态所必需的。TIPE2在淋巴组织中优先表达,其在小鼠中的缺失会导致多器官炎症、脾肿大和过早死亡。TIPE2缺陷的动物对败血症休克高度敏感,TIPE2缺陷的细胞对Toll样受体(TLR)和T细胞受体(TCR)激活反应过度。重要的是,TIPE2与半胱天冬酶-8结合,抑制活化蛋白-1和核因子-κB的激活,同时促进Fas诱导的细胞凋亡。抑制半胱天冬酶-8可显著阻断TIPE2缺陷细胞的过度反应。这些结果表明,TIPE2是TLR和TCR功能的重要负调节因子,其在免疫系统中的选择性表达可防止反应过度并维持免疫稳态。

相似文献

1
TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis.
Cell. 2008 May 2;133(3):415-26. doi: 10.1016/j.cell.2008.03.026.
2
MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2.
Cell Death Dis. 2014 Feb 27;5(2):e1095. doi: 10.1038/cddis.2014.47.
3
Research progress of TIPE2 in immune-related diseases.
Int Immunopharmacol. 2023 Aug;121:110514. doi: 10.1016/j.intimp.2023.110514. Epub 2023 Jun 20.
4
TIPE2 as a potential therapeutic target in chronic viral hepatitis.
Expert Opin Ther Targets. 2019 Jun;23(6):485-493. doi: 10.1080/14728222.2019.1608948. Epub 2019 Apr 22.
5
TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury.
J Mol Med (Berl). 2015 Sep;93(9):1033-43. doi: 10.1007/s00109-015-1288-9. Epub 2015 Apr 17.
6
Ymer acts as a multifunctional regulator in nuclear factor-κB and Fas signaling pathways.
Mol Med. 2012 May 9;18(1):587-97. doi: 10.2119/molmed.2011.00435.
7
TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal.
J Biol Chem. 2016 Oct 21;291(43):22650-22660. doi: 10.1074/jbc.M116.733451. Epub 2016 Sep 6.
9
TIPE2 in dendritic cells inhibits the induction of pTregs in the gut mucosa.
Biochem Biophys Res Commun. 2019 Feb 19;509(4):911-917. doi: 10.1016/j.bbrc.2019.01.008. Epub 2019 Jan 11.
10
Gene delivery of TIPE2 attenuates collagen-induced arthritis by modulating inflammation.
Int Immunopharmacol. 2020 Feb;79:106044. doi: 10.1016/j.intimp.2019.106044. Epub 2019 Dec 18.

引用本文的文献

1
4
TIPE2 combined with immune cell infiltration predicts prognosis in colorectal cancer.
Sci Rep. 2025 Jul 31;15(1):27954. doi: 10.1038/s41598-025-10449-5.
5
Targeting PBK with small-molecule 1--acetyl-4,6-britannilactone for the treatment of neuroinflammation.
Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2502593122. doi: 10.1073/pnas.2502593122. Epub 2025 Jul 14.
6
TIPE2: a novel regulatory factor for cardiovascular-related diseases.
J Mol Med (Berl). 2025 Jun 19. doi: 10.1007/s00109-025-02564-7.
9
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy.
Cancer Gene Ther. 2025 Apr;32(4):371-392. doi: 10.1038/s41417-025-00886-9. Epub 2025 Mar 26.

本文引用的文献

1
Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling.
J Biol Chem. 2007 Mar 9;282(10):7416-23. doi: 10.1074/jbc.M606721200. Epub 2007 Jan 9.
2
TGF-beta: a mobile purveyor of immune privilege.
Immunol Rev. 2006 Oct;213:213-27. doi: 10.1111/j.1600-065X.2006.00437.x.
3
Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation.
Curr Biol. 2006 Aug 22;16(16):1666-71. doi: 10.1016/j.cub.2006.06.062.
4
Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA.
J Immunol. 2006 Apr 15;176(8):4520-4. doi: 10.4049/jimmunol.176.8.4520.
5
Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression.
Mol Ther. 2006 May;13(5):947-55. doi: 10.1016/j.ymthe.2005.11.020. Epub 2006 Feb 7.
6
Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder.
J Exp Med. 2005 Sep 19;202(6):727-32. doi: 10.1084/jem.20050683. Epub 2005 Sep 12.
7
Requirement for caspase-8 in NF-kappaB activation by antigen receptor.
Science. 2005 Mar 4;307(5714):1465-8. doi: 10.1126/science.1104765.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验